Revier Therapeutics, a Heidelberg-based #BioTech company advancing disease-modifying #therapies for patients with #cardiometabolic disease, has launched and clo...
Revier Therapeutics, a Heidelberg-based #BioTech company advancing disease-modifying #therapies for patients with #cardiometabolic disease, has launched and closed a €6 million #Seed financing round. 🇩🇪🫀🧬💊
